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Introduction
Neutrophils are important effector cells in the innate 
immune response against invading micro-organisms [1]. 
The cells possess multiple powerful mechanisms enabling 
them to migrate towards, engage with, in particular, small 
targets and kill them intracellularly [1]. The importance of 
these cells is illustrated by the fact that neutrophils and/or 
neutrophil-like cells have already developed early in evolu-
tion [2]. Cells with phagocytic function and neutrophil-spe-
cific proteins are now found in species ranging from simple 
organisms such as sea fan corrals [3] to complex organisms 
such as mammals [4].
The evolution from simple to complex organisms resulted 
in the origin of the adaptive immune system. This review 
will focus on recent data showing the existence of multi-
ple functional phenotypes of neutrophils that, beyond their 
well-recognized anti-microbial functions, are able to steer 
and shape the adaptive immune system. But before review-
ing these functional phenotypes in detail, it is important to 
first discuss recent data with respect to: (1) definitions for 
priming and phenotypes and (2) the life cycle and compart-
mentalization of neutrophils.
Switching phenotype and priming: two distinct 
mechanisms
In this review, we define granulocytic myeloid-derived sup-
pressor cells (G-MDSCs) as a phenotype of neutrophils. A 
phenotype refers to a cell that either in the bone marrow 
or by instruction in the periphery (Fig. 1) develops towards 
a cell with a specialized function, which distinguishes it 
from other cells. In the case of G-MDSCs, this would be 
their ability to suppress the adaptive immune response. It is 
only recently that neutrophils are accepted to have multiple 
Abstract Neutrophils are essential effector cells in the 
host defense against invading pathogens. Recently, novel 
neutrophil functions have emerged in addition to their clas-
sical anti-microbial role. One of these functions is the sup-
pression of T cell responses. In this respect, neutrophils 
share similarities with granulocytic myeloid-derived sup-
pressor cells (G-MDSCs). In this review, we will discuss 
the similarities and differences between neutrophils and 
G-MDSCs. Various types of G-MDSCs have been described, 
ranging from immature to mature cells shaping the immune 
response by different immune suppressive mechanisms. 
However, all types of G-MDSCs share distinct features of 
neutrophils, such as surface markers and morphology. We 
propose that G-MDSCs are heterogeneous and represent 
novel phenotypes of neutrophils, capable of suppressing the 
immune response. In this review, we will attempt to clarify 
the differences and similarities between neutrophils and 
G-MDSCs and attempt to facilitate further research.
Keywords Myeloid-derived suppressor cells · 
Neutrophil · Inflammation · Immune regulation ·  
T-cell suppression
J. Pillay · T. Tak · V. M. Kamp · L. Koenderman (*) 
Department of Respiratory Medicine, University Medical  
Center Utrecht, HP. E 03.511, Heidelberglaan 100,  
3584 CX Utrecht, The Netherlands
e-mail: l.koenderman@umcutrecht.nl
J. Pillay 
Department of Anesthesiology, University Medical  
Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht,  
The Netherlands
3814 J. Pillay et al.
1 3
phenotypes and, surprisingly, little is known regarding the 
occurrence and induction mechanisms of these neutrophil 
phenotypes. Few examples exist of neutrophils switching 
between phenotypes and it is unknown whether neutrophils 
with different phenotypes differentiate from specialized pre-
cursors (see also below, e.g., Fig. 4). Phenotype switching 
by neutrophils has recently been reported by the addition 
of granulocyte macrophage colony-stimulating factor (GM-
CSF) to mature and immature murine bone marrow-derived 
neutrophils. These neutrophils acquired properties of den-
dritic cells such as antigen presentation but retained their 
anti-microbial properties [5].
In contrast to induction of phenotypes, priming can also 
modulate the functionality of neutrophils. Non-primed 
neutrophils are relatively refractory to activation, limiting 
aspecific activation. This process functions as a safe lock 
mechanism and has been extensively reviewed elsewhere [6, 
7]. Only after priming (typically by a cytokine, chemokine 
or bioactive lipid) can a neutrophil optimally exert func-
tions such as the generation of a respiratory burst induced 
by fMLF [8] or chemotaxis [9].
Priming is a mechanism distinct from changing of pheno-
type, as it reversibly potentiates effector functions of neutro-
phils but does not change their overall function.
The life cycle of a neutrophil
Despite the consensus regarding the importance of neutro-
phils in host defense. surprisingly little is known about very 
basic characteristics of these cells in respect to their life 
cycle. As stated above, it is only recently that neutrophils 
are accepted to have multiple phenotypes. A possible rea-
son that neutrophil subtypes were overlooked is the view 
that they are short-lived cells, which perform their duty and 
subsequently rapidly go into apoptosis in the tissue. This 
view is based on experiments labeling and tracing neutro-
phils with radioactive isotopes [10–13]. These experiments, 
which used ex vivo and potentially toxic labeling techniques, 
showed a peripheral blood half-life of only 7–25 h. Our 
recent paper using in vivo labeling with the stable isotope 
2H suggests a half-life of 3.8 days [14]. This result remains a 
matter of debate, as Li et al. [15] suggested that the observed 
results could also be explained by a 3.8-day division time 
of neutrophil progenitors. Moreover, the view that neutro-
phils in tissue cannot return to the peripheral blood has been 
challenged by several studies. Already in 1974, Vincent et 
al. [16] showed in calves that, after disappearance of most 
labeled neutrophils from blood, hydrocortisone can induce 
their return into the circulation, where they stay for at least 
another 24 h. More recently, several studies have provided 
additional evidence that support the view that neutrophils 
do not simply die by apoptosis in the tissues but move to 
additional sites in the body. These studies show homing of 
neutrophils to secondary lymphoid tissue [17] and reverse 
migration of cells over endothelium in vitro and in vivo [18, 
19]. Reverse migration and remobilization of neutrophils 
has also been shown very elegantly in zebrafish larvae dem-
onstrating migration of neutrophils from a site of inflamma-
tion toward different organs throughout the organism [20].
Taken together, these data demonstrate that at least a sub-
population of neutrophils can survive for much longer than 
previously appreciated, allowing more time for these cells to 
switch phenotypes and exert functions beyond cytotoxicity 
against invading pathogens.
Myeloid-derived suppressor cells
One of the recently described neutrophil phenotypes is the 
myeloid-derived suppressor cells (MDSCs). These cells 
were firstly identified at the beginning of this century and 
Fig. 1  Priming versus functional phenotypes of neutrophils. This fig-
ure illustrates that phenotypes are defined as cells that retain special-
ized functions for a prolonged time. Priming refers to the mechanism 
that is rapidly and reversibly induced by soluble or cell associated 
mediators such as platelet activating factor (PAF) [7], which potenti-
ate functions of neutrophils but do not change their overall function. 
Priming can potentiate all different phenotypes and functions, such as 
migration, production of ROS and phagocytosis
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described as immature myeloid cells that suppress immune 
responses in the spleens of tumor-bearing mice [21–23]. 
Such immune suppression was earlier attributed to myeloid 
cells, but this activity was confined to differentiated cells 
such as macrophages [24]. As research progressed on these 
immature myeloid cells, it became clear that they consisted 
of a heterogeneous group of cells, consisting of (precursors 
of) granulocytes and monocytes, and that these cells were 
not always immature [25]. The term myeloid-derived sup-
pressor cell was coined in 2007 by Gabrilovic et al. [26] to 
encompass the heterogeneity of these cells.
Considering the granulocytic component of MDSCs, 
there is still discussion on their differences and similari-
ties with neutrophils. Recently, research on neutrophils 
described various novel neutrophil functions, such as anti-
gen presentation, inhibition of immune responses, and 
induction of B cell class switching [27–29]. In addition, it 
has been known for decades that neutrophils reside in the 
spleen in health and disease [30], a location frequently sam-
pled for MDSCs [31–33]. As the research fields concerning 
neutrophils and granulocytic MDSCs seem to have evolved 
in separate ways, this review will attempt to clarify the dif-
ferences and similarities between these cells and attempt to 
unify and guide further research.
Identification of neutrophils and G-MDSCs
G-MDSCs are MDSCs of granulocytic origin. According to 
this definition, these cells can belong to one of three dif-
ferent types of granulocytes: neutrophils, eosinophils, and 
basophils. However, only neutrophils have been described 
as a component of MDSCs [34, 35]. Multiple surface mark-
ers and characteristics that identify G-MDSCs have been 
described. Before going into detail about the different 
G-MDSCs characteristics, we will first clearly define how 
to identify a neutrophil in order to discuss the similarities 
and differences with G-MDSCs.
Neutrophil identification
The gold standard to identify a neutrophil is by visual 
inspection under a light microscope. When stained with 
May-Grünwald-Giemsa or similar, neutrophils can be easily 
distinguished by the shape of their nucleus and cytoplasmic 
color/granularity (Fig. 2). The nucleus should either have 
a band or (hyper)segmented shape and a light pink/purple 
cytoplasm filled with similarly colored (“neutrophilic”) 
granules [36].
Identification of neutrophils by flow cytometry may be 
more convenient than visual inspection, as the latter is a 
more laborious and subjective method. In mice, flow cyto-
metric identification of neutrophils can easily be performed 
by using the neutrophil-specific marker Ly6G [37]. Tradi-
tionally, Ly6G is combined with CD11b, but this is not nec-
essary when using the specific Ly6G antibody 1A8 [37].
Human neutrophils lack a marker similar to Ly6G, but 
can be reliably identified nonetheless (Table 1). In studies on 
MDSCs, CD11b and CD33 are traditionally used as markers 
for human MDSCs. However, these markers are expressed 
on all cells of the myelocytic lineage and on NKcells, so 
they are not specific enough to identify human neutrophils 
[38–40]. Other markers used are CD14 and CD15. Neu-
trophils (or G-MDSCs) are found to be CD14neg/low and 
CD15pos, whereas monocytes (or Mo-MDSCs) are CD14high 
and CD15neg/low [35]. Unfortunately, these two markers are 
not sufficient to identify neutrophils, as eosinophils have 
a similar CD15 expression [41]. We suggest CD16 as an 
additional marker, as mature neutrophils are CD16high, 
eosinophils are CD16neg, and monocytes either CD16neg or 
CD16int. Therefore, CD16 allows for distinction between 
these two types of granulocytes. An additional advantage of 
using CD16 is that its expression varies between the differ-
ent stages of neutrophil maturation: neutrophil progenitors 
capable of dividing are CD16neg, with increasing expres-
sions in metamyelocytes, banded and mature neutrophils, 
respectively [38]. CD16 alone is not enough to identify 
neutrophils, since NK cells and monocytes also express this 
marker [42].
In short, we suggest the use of Ly6G for identification 
of murine neutrophils and the combination of CD14, CD15 
and CD16 for identification of human mature neutrophils. 
We do want to emphasize the importance of visual inspec-
tion, which remains the gold standard to identify neutro-
phils. Visual inspection should routinely be performed in 
order to eliminate the possibility of other cell types express-
ing neutrophil markers under certain clinical conditions.
G-MDSCs versus neutrophils
As mentioned above, G-MDSCs have been implicated to 
have a similar expression of CD14 and CD15 as neutrophils, 
while mature or banded G-MDSCs and neutrophils also 
have similar CD16 expression. However, there seems to be 
one prime feature that distinguishes them from normal neu-
trophils: immune suppression. Several methods have been 
proposed to distinguish between the suppressive G-MDSCs 
and circulating neutrophils and will be discussed below.
Identification of G-MDSCs: flow cytometry
Several papers have shown differences between G-MDSCs 
and normal neutrophils in the expression of cell surface 
markers visualized by flow cytometry. Greifenberg et al. 
[43] identified two subsets of neutrophils with a different 
CD11b expression in the spleens of healthy mice. Of these 
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two populations, only the relatively low (but still positive) 
CD11b-expressing cells were found to be immune suppres-
sive and, therefore, exhibited characteristics of G-MDSCs. 
Youn et al. [44] found an increased proportion of neu-
trophils expressing SLAMF4 (CD244) in mice bearing 
several different tumors. In some, but not all, of these tumor 
models, there was also an increased population of neutro-
phils expressing CSF1-R (CD115). When they compared 
the CD244-positive and -negative populations, only the 
CD244pos cells were found to be immune suppressive. The 
consequences of these findings for the human situation 
remain to be established.
In humans, an enhanced expression of the IL-4Rα 
(CD124) was found on suppressive cells. This marker was 
found on the G-MDSCs of patients with non-small cell 
lung carcinoma [45]. However, another paper found CD124 
expression to correlate only with immune suppression by 
monocyte-derived MDSCs [46]. Therefore, it remains 
uncertain whether CD124 can be used to identify human 
G-MDSCs.
In severely injured patients and in a human acute 
inflammation model, our group has identified distinct 
Fig. 2  Schematic representations and images of the nuclear morphol-
ogy of human and murine neutrophils during subsequent stages of 
development. Myelocytes mature into metamyelocytes, banded neu-
trophils, and finally into mature segmented neutrophils. Neutrophils 
may also become hypersegmented, with more than 4 nuclear lobes 
(human) or a cloverleaf shape (mouse). It is unknown whether hyper-
segmented neutrophils are more mature than segmented neutrophils
Table 1  Expression of the markers commonly used to identify 
human neutrophils or G-MDSCs
Neutrophil 
(mature)
Eosinophil Monocyte NK cell
CD14 ± − ++ −
CD15 ++ ++ ± −
CD16 ++ − + ++
CD11b ++ ++ ++ ++
CD33 + + + +
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neutrophil subsets of which the CD62Ldim/CD16bright subset 
was immune suppressive [29]. In contrast to the findings by 
Greifenberg, who showed G-MDSCs to be lower in CD11b 
expression, this CD62Ldim/CD16bright subset showed a trend 
of higher CD11b expression [43]. Other markers upregulated 
in these suppressive cells were CD11c, CD32, CD35, CD45, 
and CD66b. The suppressive cells could, however, not be 
clearly distinguished on the basis of these latter markers.
Puga et al. [28] show two different subtypes of neutro-
phils in the human spleen, named NBH1 and NBH2 (B cell 
helper neutrophils). These subtypes have a higher expres-
sion of B cell activating factor (BAFF) and CD11b, and 
lower expressions of CD15, CD16, CD62P, and CD62L 
compared to blood cells. Additionally, the NBH2 cells have 
a higher CD27, CD40L, CD86, and HLA-II compared to 
both circulating and NBH1 neutrophils. Unfortunately, they 
only assessed immune suppression by splenic neutrophils as 
a whole. Therefore, it is unclear whether only one of these 
two subtypes or both are suppressive and which markers can 
distinguish between suppressive and normal neutrophils.
In conclusion, many markers are shown to distinguish 
suppressive G-MDSCs from non-suppressive neutrophils. 
However, so far, none of these candidates have been con-
firmed by other papers and some findings are contradictory 
(e.g., CD11b, IL-4Rα). Thus, to date, no single or combined 
expression of surface markers can reliably identify suppres-
sive neutrophils or G-MDSCs in either humans or mice.
Identification of G-MDSCs: density centrifugation
Centrifugation of blood over a layer with a density of 
1.077 g/ml is a common step in the isolation of leukocytes 
from whole blood [47]. Due to their relatively high density, 
neutrophils end up below the layer, on top of the erythro-
cyte fraction, whereas the PBMC fraction is found in the 
interphase between this layer and the plasma. Schmielau 
and Finn [48], and Rodriquez et al. [49] found immune sup-
pressive G-MDSCs in the PBMC fraction of cancer patients. 
These cells show an activated phenotype, characterized by 
increased CD66b and CD11b expression. Also, they show 
the immune suppression to be mediated by the CD66b-
expressing cells [49]. However, they did not show whether 
the neutrophils with normal density in the same patients 
were also suppressive, and therefore it remains uncertain 
whether density centrifugation can distinguish between sup-
pressive and non-suppressive cells. In vitro activation of neu-
trophils from healthy donors resulted in neutrophils with a 
similar density and suppressive capabilities, indicating that, 
in this system, G-MDSCs might be activated neutrophils 
[49]. Density centrifugation remains a widely used method 
for the isolation of human MDSCs in cancer patients, but 
there is still a lack of data on the differences between these 
G-MDSCs and neutrophils from these patients [50].
Identification of G-MDSCs: gene profiling
Even though it is not possible to isolate cells based on gene 
expression patterns, it is likely that cells with different func-
tions will have different gene expression profiles. Fridlender 
et al. [51] showed differences in the transcriptome of naïve 
bone marrow neutrophils in healthy mice, blood G-MDSCs 
from tumor-bearing mice, and tumor-associated neutro-
phils (TANs). The cells from the blood of tumor-bearing 
mice have a low expression of mRNA for cytokines and 
chemokines compared to TANs. Compared to bone marrow 
cells, G-MDSCs show a low mRNA expression of gran-
ule proteins, NADPH complex subunits, and peroxidases. 
Unfortunately, the location of neutrophils can influence 
their functionality [52], so it is unclear whether these dif-
ferences were specific for G-MDSCs or a result of different 
localization/maturation. For instance, it is likely that neu-
trophils produce their granule and respiratory burst proteins 
during maturation and store them for later use, explaining 
the high amounts of mRNA for these proteins [53, 54].
Another transcriptome analysis by Youn et al. [44] com-
pared neutrophils from naïve and tumor-bearing mice. It 
showed an upregulation of MPO and proteins involved in 
cell-cycle pathways in G-MDSCs from tumor-bearing mice. 
In contrast, neutrophils from naïve mice show an upregu-
lation in mRNA for cytokines, chemokines, proteases, and 
other pro-inflammatory proteins.
Other proteins found to be upregulated in G-MDSCs are 
arginase-I [49, 51, 55, 56], iNOS [57], and IL-10 [55]. As 
these three proteins are directly involved in mechanisms of 
immune suppression by G-MDSCs, they will be described 
in more detail in the section below.
Identification of G-MDSCs: nuclear morphology
MDSCs are in general described as young or immature 
cells [58]. The nuclear morphology of neutrophils provides 
a simple tool to assess their age. Neutrophils possess a 
distinct nuclear morphology in different stages of devel-
opment (Fig. 2). Early progenitors have a round nucleus, 
which changes during maturation into the horseshoe, or 
“banded”, shape of a human immature neutrophil (a ring-
shape in mice). When these cells fully mature, the nucleus 
starts showing indentations and is called segmented. When 
the nucleus has 4 or more segments in humans, or a clover-
leaf-shape in mice, it is called hypersegmented. Since neutro-
phils gain more indentations and segments upon maturation, 
it is tempting to address hypersegmented cells as “old”. 
However, there is evidence that segmented and hyperseg-
mented neutrophils in humans are of similar age [59].
In the paper of Greifenberg et al. [43] mentioned above, 
the G-MDSCs population had a clear ring-shaped morphol-
ogy, whereas the cells with a segmented nucleus were not 
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suppressive. This supports the notion of G-MDSCs being 
young/immature cells. Also, Fridlender et al. showed in a 
tumor model that immune suppressive TANs are mostly 
immature, whereas, after TGF-β inhibition, the TANs were 
found to be hypersegmented and did not suppress tumor 
growth, thus implying loss of immune suppression [37].
Other papers, however, shave shown no difference in 
nuclear morphology for the suppressive cells [44, 60]. 
Similarly, Dumitru et al. [35] have extensively reviewed the 
phenotype of suppressive G-MDSCs in human cancers and 
found them to be segmented in 8 out of 9 papers where the 
nuclear morphology was assessed [45, 48, 49, 56, 61–64]. In 
addition, in our model of acute inflammation and in severely 
injured patients, we have shown only the hypersegmented 
cells to be immune suppressive [29].
Taken together, nuclear morphology is not a good indi-
cation for immune suppressive functions and, therefore, of 
G-MDSCs. However, these differences do indicate the exist-
ence of several distinct G-MDSCs subtypes.
G-MDSCs identification and subtypes: conclusion
When studying potential G-MDSCs (or suppressive neutro-
phils), one should first ascertain the cells of interest to be 
neutrophils. This can be done by flow cytometric determi-
nation of CD14, CD15, and CD16 expression and, ideally, 
assessing nuclear morphology after cell sorting. Density 
centrifugation is not a suitable method for isolating suppres-
sive neutrophils, as it cannot distinguish suppressive cells 
from non-suppressive activated cells.
In various studies, different surface markers are shown 
to distinguish G-MDSCs or suppressive neutrophils from 
their non-suppressive counterparts. However, there are dif-
ferences in expression of (activation) markers and nuclear 
morphology between these suppressive subsets. This demon-
strates that there are several G-MDSCs phenotypes, possibly 
reflecting differences in localization, clinical condition, or 
origin.
Mechanisms of immune suppression by suppressive 
neutrophils and G-MDSCs and their relevance to 
disease
Proliferation of T cells is influenced by many environmen-
tal factors. These factors, such as cytokines, growth factors, 
and amino acids, are easily altered in an inflammatory envi-
ronment in the presence of other inflammatory cells such as 
neutrophils and G-MDSCs. Suppression of T cell responses 
can be achieved by depletion of essential amino acids from 
the microenvironment, such as l-arginine [65], (massive) 
generation of reactive oxygen species [48], or through cell–
cell contact (Fig. 3) [29].
Production of anti-inflammatory cytokines such as IL-10 
by neutrophils has been proposed [60, 66]. However, this 
was only observed in murine neutrophils [67] and will, 
therefore, not be discussed in this review.
Recently, studies have shown that, in addition to limit-
ing T cell responses, G-MDSCs limit NK-cell responses 
and activation to vaccinia virus [68]. This was dependent on 
H2O2 production by G-MDSCs. Other studies have shown 
reduced NK-cell responses by G-MDSCs in pregnancy, can-
cer, and in the tumor environment; however, no mechanism 
of suppression was reported [69–71].
The role of arginase in T cell suppression by MDSCs
Arginase-1 (ARG1) was shown to be important in the sup-
pression of immune responses by MDSCs in various murine 
models [72]. ARG1 metabolizes l-arginine into l-ornithine 
and urea. This depletes l-arginine from the micro-environ-
ment. The amino acid l-arginine has multiple roles such as 
its importance in wound healing [73]. In addition, it is the 
only endogenous substrate for the production of nitric oxide 
(NO) by inducible nitric oxide synthase (iNOS) [74]. l-argi-
nine is necessary for T cell proliferation, as, in the absence 
of l-arginine, the cell cycle of proliferating T cells arrests in 
the G0–G1 phase. [65].
Several mechanisms have been described to explain this 
l-arginine depletion mediated inhibition of proliferation. 
Fig. 3  Mechanisms of suppression by G-MDSCs and suppressive 
neutrophils. Suppression can be mediated by extracellular arginase, 
extracellular ROS, or ROS in an immunological synapse. Al these 
mechanisms result in reduced T cell proliferation, via decreases in 
extracellular l-arginine, cofilin, TCRζ expression, NF-κB activation, 
or unknown mechanisms
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l-arginine influences the expression of the T cell receptor ζ 
chain (TCRζ, CD247) [75], and ARG-1 has been shown to 
downregulate TCRζ expression and T cell activation at the 
level of TCR expression [76, 77]. The TCR/CD3 expression 
is regulated by continuous internalization and recycling of 
receptors. The level of surface expression of the receptor 
regulates the ability of a T cell to become activated. The 
rate of synthesis of the TCRζ-chain is rate limiting to that of 
the other TCR/CD3 chains. Therefore, this chain is critically 
important in the regulation of TCR/CD3 internalization and 
recycling as it stabilizes the TCR/CD3 complex on the cell 
membrane. [78]. A second mechanism by which a depletion 
of l-arginine results in T cell suppression has recently been 
described. Feldemeyer et al. show that dephosphorylation of 
cofilin is decreased by depletion of l-arginine. Cofilin is a 
protein necessary for the remodeling of F-actin [79], which 
is essential for the formation of an immunological synapse 
and T cell proliferation [80].
ARG1 is widely expressed in murine myeloid cells and 
macrophages. However, in humans, it has only convinc-
ingly been shown in neutrophils [34, 81]. Neutrophil ARG1 
is synthesized in their myelocyte and metamyelocyte 
stages and is located in the gelatinase containing granules 
of mature neutrophils [53, 81]. It is implicated in the host 
defense against fungi [81]. Activated neutrophils exocytose 
a form of ARG1 that is catalytically active at pH 9.5–10.5 
[53, 82]. This ARG1 becomes active at a physiological 
pH of 7.5 only after cleavage by a co-factor. The co-factor 
responsible for this cleavage has not been identified, but it 
has been suggested to be located in azurophil neutrophil 
granules.
Release of ARG1 by neutrophils requires cellular acti-
vation and degranulation of both tertiary (gelatinase) and 
azurophllic granules. As stated above, human MDSCs have 
been shown to co-localize with PBMCs when isolated by 
density separation. Interestingly, fMLF-activated neutro-
phils from healthy volunteers show similar behavior and 
co-localize with PBMCs [48]. In patients suffering from 
severe traumatic injury, the increase of ARG1 activity has 
also been attributed to activated neutrophils in the PBMC 
fraction [83]. In addition, increased serum ARG1 correlates 
with degranulated neutrophils in patients with glioblas-
toma multiforme [63]. These findings could implicate that 
G-MDSCs in humans that inhibit T cell proliferation via an 
ARG1-mediated mechanism are simply activated granulo-
cytes [49].
As described above, ARG1 expression in myeloid cells 
of mice and humans is essentially different [84]. Human 
studies have only correlated the degree and occurrence of 
ex vivo measured ARG1-mediated T cell suppression to 
disease progression. Murine studies mostly focused on the 
association of ex vivo T cells suppression and occurrence of 
MDSCs in the spleen. The direct contribution of MDSCs to 
in vivo T cell suppression in T cell-mediated diseases has 
remained largely uninvestigated, although, recently, ARG1 
has been shown to limit graft versus host disease (GVHD) 
in mice. In this study, ARG1-expressing monocytic MDSCs 
were generated by ex vivo incubation with G-CSF, GM-
CSF, and IL-13. Adoptive transfer of these ARG1-express-
ing cells or administration of pegylated-ARG1 limited 
pathology in this model [72].
Reactive oxygen species
A hallmark of neutrophils and G-MDSCs is the potential to 
produce large amounts of reactive oxygen species (ROS). 
These are generated by the NADPH–oxidase complex in 
neutrophils. A detailed and schematic description of the 
generation of ROS is presented by Nathan and Ding [85]. 
Generation of superoxide anion (O2−) is the first oxygen 
radical produced. O2− can be converted to two substances 
that have been shown to mediate lymphocyte suppression. 
Firstly, O2− can react with NO, producing reactive nitrogen 
species such as peroxynitrite. NO is generated by inducible 
nitric oxide synthase (iNOS) using l-arginine as substrate, 
linking the generation of reactive nitrogen species to l-argi-
nine metabolism as described above. Reactive nitrogen spe-
cies are utilized in some models by monocytic MDSCs, but 
not by G-MDSCs and neutrophils, and will, therefore, not 
be discussed in this review [58].
The second substance formed from O2− is H2O2 (hydro-
gen peroxide). H2O2 can be converted by myeloperoxidase 
to hypochlorous acid (HOCl−). H2O2 can suppress lympho-
cyte proliferation through various mechanisms by inducing 
apoptosis, decreasing Nf-κB activation, downregulating 
TCRζ, and oxidation of cofilin [86–88].
Cofilin remodeling of F-actin is essential for the T cell 
effector function. Oxidation of cofilin results in its loss 
of Ser3 phosphorylation [87]. Dephosphorylated cofilin 
is unable to mediate actin depolimerization, thus severely 
disturbing actin dynamics and impairing T cell activation 
[80]. Similar to l-arginine depletion, oxidative stress cor-
relates with TCRζ expression, although the exact mecha-
nism is not known. In addition, oxidative stress blocks 
Nf-κB activation leading to impaired T cell activation 
[88].
Of note is that regulatory T cells have been shown to be 
resistant to oxidative stress [89]. This suggests that regu-
latory T cells are less suppressed than other T cells, thus 
enhancing the overall suppressive effect of H2O2 in vivo.
Suppression of T cell activation and proliferation requires 
high concentrations of H2O2 [48, 87], which can be pro-
vided by the presence of large numbers of neutrophils at the 
site of T cell activation. This might be due to the fact that 
hydrogen peroxide is unstable and is rapidly converted to 
H2O and O2. Indeed, activated neutrophils or G-MDSCs in 
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cancer patients have been shown to inhibit T cell responses 
in a H2O2-dependent manner [48].
The relevance of H2O2 in the context of G-MDSCs or 
neutrophil-mediated suppression is difficult to study in 
animal models. This is mainly due to the diverse biologi-
cal functions of H2O2. Besides immune suppression, H2O2 
and its metabolites are involved in bacterial killing [90]. 
In addition, it functions as a signaling molecule necessary 
for diverse cellular functions [90] including chemotaxis 
of immune cells. It has recently been shown that H2O2 is 
a potent inducer of chemotaxis of neutrophil-like immune 
cells in a model of tissue injury in zebrafish [91]. Hydro-
gen peroxide might, therefore, also indirectly contribute 
to microbial clearance by attracting immune cells and kill-
ing bacteria. These functions of H2O2 are indispensable in 
immune processes and, therefore, complicate the interpreta-
tion of studies targeting H2O2 to define its role in immune 
suppression by G-MDSCs.
Caution must be taken in interpreting ex vivo suppression 
of T cell proliferation mediated by H2O2. Manipulation and 
isolation of neutrophils and G-MDSCs might lead to cell 
priming and aberrant activation. Also, adhesion to plastic 
culture dishes might result in cellular activation, degranu-
lation, and reactive oxygen species production resulting in 
vitro suppression of T cell responses [92]. Activation of large 
number neutrophils from healthy volunteers has been shown 
to suppress T cell responses ex vivo [87]. Therefore, at least 
two possibilities exist on how H2O2 results in immune sup-
pression in vivo. Firstly, a general oxidative environment 
described by Klemke et al. in which ‘normal’ activated 
neutrophils mediate immune suppression. Secondly, as 
described below, small amounts of H2O2 can be delivered 
via the formation of an immunological synapse providing 
specific and direct suppression of T cell responses. It would 
be useful to distinguish between these two mechanisms in 
future studies concerning G-MDSCs and neutrophil sup-
pression by H2O2.
Immunological synapse formation, the requirement of cell-
to-cell contact
The potency of the above-described suppressive mecha-
nisms would be greatly enhanced by cell-to-cell contact 
and the formation of an immunological synapse. H2O2 has 
a short half-life and can be degraded by many endogenous 
anti-oxidants. Therefore, release into a synapse would 
potentiate and concentrate local concentrations of H2O2, 
H2O2 is produced in an immunological synapse between 
T cells and macrophages and dendritic cells during anti-
gen presentation, and results in decreased lymphocyte 
activation [93, 94]. We have recently shown that a sub-
set of neutrophils in human inflammation is capable of 
directly delivering H2O2 to the surface of lymphocytes and 
thereby limiting T cell activation and proliferation [29]. 
This contact was dependent on CD11b/CD18, an integrin 
abundantly expressed by the G-MDSCs in mice. However, 
in mice, no requirement of cell-to-cell contact suppression 
by G-MDSCs was found. A very recent study showed that, 
in patients with gastric cancer, G-MDSCs isolated from 
the tumor site suppressed T cells in a contact-dependent 
manner [95]. Regretfully, no experiments were performed 
in this latter study to further elucidate the suppressive 
mechanism.
Distribution of neutrophils and G-MDSCs in lymphoid 
organs
In order to modulate the function and proliferation of T 
cells, neutrophils or G-MDSCs need to come in contact 
with or in close proximity to T cells [96]. T cell prolif-
eration is normally considered to take place in secondary 
lymphoid organs such as lymph nodes and the spleen [97]. 
Recently, T cell proliferation has also been shown at the 
site of inflammation [98, 99]. In order to suppress these 
T cells, neutrophils will have to be present at these sites. 
Indeed, many studies show neutrophil homing to sites of T 
cell proliferation, which will be reviewed in the following 
section.
Neutrophils in lymphoid organs
Spleen
Neutrophils are known to migrate to the spleen under both 
homeostatic and pathological conditions [30]. Reinfusion 
of ex vivo 111Indium-labeled neutrophils in healthy controls 
showed the majority of label in the bone marrow, spleen, 
and liver [30, 100]. These studies imply that considerable 
amounts of neutrophils rapidly home to the spleen after 
release from the bone marrow. In addition, in mice, about 
10 % of reinfused radiolabeled neutrophils migrated towards 
the spleen, which was not influenced by the maturation sta-
tus of neutrophils or inflammation [101]. It is important to 
emphasize that ex vivo manipulation of the cells could have 
induced subtle changes affecting their homing behavior in 
vivo [102].
In the spleen, under normal homeostatic conditions, 
neutrophils reside on the border of the red and white pulp 
[103, 104] and the marginal zone, whereas T cells are found 
in the white pulp [103]. Consequently, neutrophils should 
migrate to the white pulp in order to contact the T cells or 
vice versa. Neutrophil migration to the white pulp has been 
shown after intraperitoneal injection of LPS in mice. This 
was shown to be CD14-dependent [104]. Also, after surgical 
trauma, neutrophils were found to co-localize with T cells 
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in the spleen [77]. These data demonstrate that neutrophils 
migrate towards the T cell zones of the spleen in acute sys-
temic inflammation.
Lymph nodes
During inflammation, neutrophils are found to migrate 
to lymph nodes [17, 105–111]. Already in 1987, neutro-
phil trafficking from lung to draining lymph nodes was 
described in dogs [1]. In this study, fluorescent micro-
spheres were instilled in the lung of dogs and phagocy-
tosed by neutrophils and macrophages. After 40 h, almost 
half of the cells in the draining lymph node were neu-
trophils containing microspheres [105]. Also, in a more 
physiological model of antigen uptake [111], neutrophils 
can migrate to draining lymph nodes [17, 106]. Neutro-
phils were detected in lymph nodes during infections with 
Mycobacterium bovis [107], Salmonella [108], and dif-
ferent parasites [109–111]. In some of these models, neu-
trophils were shown to alter [17, 111] or even inhibit the 
inflammatory response [106, 110]. The route of migration 
toward the lymph nodes [107–111] was via the lymphatic 
system [17, 105–107, 109].
Suppressive neutrophils and G-MDSCs in the spleen
Almost all studies regarding G-MDSCs in the literature 
were performed with Ly6G-positive cells isolated from the 
spleen [31–33]. However, not all of these Ly6G-positive 
neutrophils in the spleen can suppress T cells [43]. An influx 
of G-MDSCs into the spleen in mice has been seen both in 
acute and chronic inflammation such as cancer models [31], 
parasite infection (Trypanosoma cruzi) [32], and superanti-
gen stimulation (Staphylococcal enterotoxin) [33]. Numbers 
of G-MDSCs were increased up to 10-fold 14 days after 
Trypanosoma cruzi infection [32]. During superantigen 
stimulation, suppressive neutrophils with highly segmented 
nuclei were sorted from the spleen [33]; these cells bear a 
resemblance to the hypersegmented CD16bright/CD62Ldim 
neutrophils that are found in the blood after LPS challenge 
[29].
Some cancer models increase hematopoiesis, resulting in 
increased cycling of hematopoietic stem cells and hemat-
opoietic activity in the spleen [112]. Younos et al. showed 
by in vivo BrdU labeling that in tumor-bearing mice gran-
ulocytic proliferation mainly takes place in the spleen, 
whereas, in control mice, granulocytic cells predominantly 
proliferate in the bone marrow [113]. The CD3+ cells in 
this model proliferate less in the tumor-bearing mice, but, 
unfortunately, they do not show that this immune suppres-
sion is a direct effect of the spleen granulocytes. There were 
also no microscopic pictures of these cells to show their 
maturation stage [113].
Suppressive neutrophils and G-MDSCs in the lymph nodes
Fewer data are available to show suppressive neutrophils 
or G-MDSCs in lymph nodes. Sepsis induced an influx 
of immature myelocytes capable of T cell suppression in 
lymph nodes. These cells could be detected 10–14 days after 
sepsis and remained present in the lymph nodes for at least 
12 weeks after sepsis. Cytospins obtained during this study 
showed a heterogeneous group of cells consisting of both 
monocytic and granulocytic origin [114].
Vascular endothelial growth factor (VEGF) is able to 
induce MDSCs in cancer models and is a factor important 
for immune evasion in several cancer models [115]. Upon 
infusion of VEGF, myeloid cells, including neutrophils, 
were massively increased in lymph nodes [116]. Unfortu-
nately, the capacity of these granulocytes to suppress T cells 
was not tested. Another indication that MDSCs can migrate 
to lymph nodes came from a study of Watanabe et al. [117]. 
They showed that proliferation of T cells in the lymph 
nodes of leukocyte-depleted mice was low when injected 
with spleen cells (containing both T cells and MDSCs) from 
tumor-bearing mice, compared to proliferation after injec-
tion with control mice spleen cells [117]. Proliferation was 
measured in vitro using cells isolated from lymph nodes. 
Unfortunately, this model did not discriminate between 
granulocytic and monocytic MDSCs, so further research is 
necessary to draw definite conclusions about the presence 
and importance of suppressive neutrophils in lymph nodes.
T cell proliferation outside the lymphoid organs
T cell proliferation is not restricted to lymphoid organs, 
because T cell proliferation was also found, e.g., at sites of 
viral infection [98, 99, 118–121]. In influenza infection, pro-
liferating T cells in the lungs contribute substantially to the 
total number of cytotoxic T-cells in the lung [98, 118]. Also, 
the persistence and reactivation of influenza-specific CD8+ 
memory T-cells can take place in mice without secondary 
lymphoid organs [119]. Similarly, CD8+ T cells proliferate 
outside the secondary lymphoid organs in a model of Her-
pes simplex virus (HSV) reactivation. In this model, infected 
sensory dorsal root ganglia (DRGs) are transplanted into 
naïve mice, inducing proliferation in the DRGs of both 
memory CD8+ T cells from graft [99] and newly recruited 
CD8+ T cells from the host [120]. Even further, in RSV 
infected mice, CD4+ memory T cells proliferate and differ-
entiate in the lung, but not in the lymph nodes [121].
Taken together, this shows that T cells can proliferate at 
sites of viral infection, which is exactly the place where vast 
amounts of neutrophils are found [122, 123]. Therefore, 
although it may contribute, neutrophil migration towards 
the secondary lymphoid organs is not necessary to dampen 
the immune response.
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Origin of G-MDSCs and suppressive neutrophils
Many papers have shown only a subset of neutrophils to 
be suppressive. Even further, these suppressive subsets 
show differences in (flow cytometric) expression patterns 
and nuclear morphology [28, 29, 44–46]. The difference 
between normal neutrophils and the different types of sup-
pressive neutrophils may lie in the presence of cytokines or 
growth factors, (e.g., G-CSF and VEGF) [115, 116, 124] 
in localization, or in their origin [28]. Few studies have 
addressed the origin of suppressive phenotypes, and there-
fore we will briefly discuss four hypotheses regarding the 
origin(s) of these suppressive cells (Fig. 4):
(a) Suppressive neutrophils might originate from normal, 
fully maturated cells. These cells acquire a suppressive 
phenotype under certain (inflammatory) conditions. 
They can either retain their mature nuclear morphology 
(Fig. 4, 1m) or become hypersegmented (Fig. 4, 1h).
(b) Cells do not fully mature before exiting from the bone 
marrow. Progenitors have been found in the peripheral 
blood under conditions of severe systemic inflammation 
caused by infection or trauma [125, 126]. These cells 
are neutrophil progenitors, which migrate to the tissue 
and subsequently become suppressive.
(c) An altered or a dedicated suppressive granulopoiesis, 
underlie the production of G-MDSCs, as suggested 
by the role of G-CSF in several papers [72, 124]. This 
results in either immature (Fig. 4, 3i) or mature (Fig. 4, 
3m) cells with a suppressive phenotype.
(d) Instead of being produced in the bone marrow, sup-
pressive cells might be produced by extramedullary 
granulopoiesis. This would result in either immature 
(Fig. 4, 4i) or mature (Fig. 4, 4m) cells with a suppres-
sive phenotype. For example, Youn et al. [44] described 
G-MDSCs from tumor-bearing mice were produced 
in the spleen, whereas neutrophils from healthy mice 
originated from the bone marrow.
At this moment, it is unclear which of these mechanisms 
underlie the induction of G-MDSCs and whether multi-
ple mechanisms co-exist. Further research is required to 
elucidate the origin of different suppressive phenotypes, 
and whether differences between suppressive phenotypes 
are caused by differences in their origin or by alternative 
activation.
A novel hypothesis: G-MDSCs are a phenotype of 
neutrophils
Neutrophils do not belong to a single homogenous popu-
lation of cytotoxic cells with a sole function to eliminate 
invading microorganisms. In fact, these cells can engage 
Fig. 4  The origin of G-MDSCs remains unknown. Hypothetically, 
these calls can arise from mature (1) or immature (2) neutrophils 
receiving signals to become suppressive. Alternatively, there may be 
a dedicated granulopoiesis, which only produces suppressive cells. 
This granulopoiesis can take place either in the bone marrow (3) or 
extramedullary (4). Additionally, these cells can be immature (i), 
mature (m) or hypersegmented (h)
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with and modulate T cells and, thereby, shape the adaptive 
immune system. The lack of consensus regarding nomencla-
ture of these suppressive cells, their heterogeneity, and the 
lack of suppressive assays in many studies makes it difficult 
to draw overall conclusions. However, these studies support 
the hypothesis that multiple types of suppressive neutrophils 
exist, capable of mediating immune suppression by differ-
ent mechanisms. Given the recent advances in neutrophil 
biology, illustrating their plasticity, we hypothesize that 
G-MDSCs might be a functional heterogenic subset of neu-
trophils. At this time, it is uncertain how many neutrophil 
phenotypes exist. It is, however, clear that targeting neutro-
phils or G-MDSCs as clinical intervention is only effective 
with knowledge of the different pro- and anti-inflammatory 
phenotypes, and when origin and kinetics of these cells are 
adequately elucidated.
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